Frequency Therapeutics

Frequency Therapeutics is a biotechnology company headquartered in Lexington, Massachusetts. The company employs 22 individuals and reported $9.4 million in revenue. Frequency Therapeutics is focused on developing innovative therapeutics within the field of regenerative medicine. Their core technology, the progenitor cell activation platform, seeks to harness the body's natural healing capabilities by activating specific cells for therapeutic benefit. Their primary research focuses on activating oligodendrocyte precursor cells, a key step towards remyelination, with the ultimate aim of providing functional recovery for individuals living with multiple sclerosis. What sets Frequency Therapeutics apart is its novel approach to treating diseases by stimulating the body's own regenerative processes. Their progenitor cell activation platform represents a potentially transformative advancement in medicine, offering a new avenue for addressing a range of debilitating conditions. To learn more about Frequency Therapeutics and their groundbreaking work, visit their website at frequencytx.com.